The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA May Reverse Ban on 14 PeptidesWhat It Means for Your Beauty Routine Allure Demand for Unapproved Weight Loss Drug Surges on Social Media MedPage Today Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance Sports Medicine Springer Nature Link The peptide problem: Hype is outrunning the evidence The "Body Protection Compound": A Deep Dive into BPC 157 DiFrancesco Plastic Surgery